EuroMusk76

At least he EMA (European Medicines Agency) speaks of similar levels of antibodies, not a better response when using intradermal injections. It cautioned however that the study had had only healthy subjects, thus reliable conclusions as to the effect in immunocompromised persons or people living with HIV+ can't be drawn. [think before following links] https://www.ema.europa.eu/en/news/emas-emergency-task-force-advises-intradermal-use-imvanex-jynneos-against-monkeypox For an in-depth analysis look at the pdf under related documents. Let's see when member states and their constituent parts will follow this advice. Unfortunately they are sometimes slow on the uptake.

Take a look at the guys around you at Folsom. If they are all prim and proper (yeah, I know, what are the chances of that) and a genuine police officer stands close by, you probably shouldn't try to suck and fuck. If they are a raunchy bunch, well go for it, but don't try to overdo it, be circumspect. Go for your goals.

There are a lot of parks where you can go cruising in Berlin. Best known are Tiergarten, Hasenheide, Volkspark Friedrichshain, and Grunewald. Have a look at the following guides for descriptions and even more suggestions. There should be something for everyone's taste. in English : [think before following links] https://awesomeberlin.net/berlin-gay-cruising-guide/ in German, but due to user comments more up to date (FYI "Klappe" means cottage in British English or tearoom in American English): [think before following links] https://gay-szene.net/gay-cruising-in-berlin/25/17/rubrik.html As to the legality of sex outdoors in a park or on a balcony, it's a bit more complicated than you stated. German law knows the misdemeanor "Erregung öffentlichen Ärgernisses" which translates as indecent behaviour or scandalisation. Basically if the people having sex are intending to be seen and are seen by the public they commit this offense. If however they take care of hiding away from prying eyes, for example in bushes or by having sex on a balcony at night, they should be safe, if no-one else is disturbed. That said, Berlin is pretty tolerant and most Cruising spots are well known. Fellow cruisers are more likely to join in than report you to the authorities. On some festivals, e.g. Folsom Europe, the mores might be a bit loser than the rest of the year. Use some common sense: stay safe and sane. The days where police used to entrap or hunt for cruisers are gone in Berlin. But you would be ill-advised to fuck in front of the Brandenburg Gate or on the top of the Reichstag in the middle of the day.

The Guardian reports a study published in The Lancet on MPX cases in Spain found that a childhood smallpox vaccinations may not protect against MPX for life and that HIV+ individuals might run a higher risk of infection despite being vaccinated in their youth. [think before following links] [think before following links] https://www.theguardian.com/world/2022/aug/15/smallpox-vaccines-protect-monkeypox-hiv-erode [think before following links] [think before following links] https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01436-2/fulltext

As to the UK's 29 new cases per day on average mentioned in the BBC article that seems to be an older figure. As one can conclude from the number of total cases (3,017) it comes from the epidemiological overview, 9 August 2022. There you had 158 total new cases (167 confirmed and 12 highly probable) from 4 August to 8 August. That would mean about 204 confirmed new cases a week. The WHO mentions just 36 new cases a week as of 17 August. The UKHSA gives a number of 178 total new cases (146 confirmed and 11 highly probable) as of 15 August. That corresponds to a new cases per day average of 21. So there is a marked decrease in new cases in the UK. [think before following links] [think before following links] https://www.bbc.com/news/uk-62551821 [think before following links] [think before following links] https://www.gov.uk/government/publications/monkeypox-outbreak-epidemiological-overview/monkeypox-outbreak-epidemiological-overview-16-august-2022 Across most of Europe confirmed new cases of MPX seem to be on the decline. According to the ECDC as of 15 August the highest number of new cases in the last 7 days were in Spain (777), Germany (212), Portugal (60), France (52), Denmark (33), Austria (24), Italy (11), Ireland (9), and the Netherlands (7). [think before following links] [think before following links] https://www.ecdc.europa.eu/en/monkeypox-multi-country-outbreak/situation-update-eueea-western-balkans-turkey However according to the WHO as of 17 August the highest number of new cases in the last 7 days were in Spain (630), France (326), Germany (162), Belgium (78), the Netherlands (70), Portugal (60), Italy (63), Austria (41), Denmark (26), Ireland (12), and Hungary (11). Most notable are the discrepancies between ECDC and WHO figures in the cases of France, Belgium, the Netherlands, Italy, Austria, and Hungary. Some countries have bucked the European wide trend and have seen a somewhat sharpish 7-day percentage change in new cases, e.g. Ireland (+200%) and the Netherlands (+120%). [think before following links] [think before following links] https://worldhealthorg.shinyapps.io/mpx_global/#section-global

MPX might not be as deadly as HIV/AIDS was in the early years, and there is a modern vaccine available for smallpox which may protect you from getting MPX, that's true. If you looked at it from different angles you'll find there are similarities. I don't just refer to the sluggish response from governments the world over which some may ascribe to institutional homophobia. These diseases affected predominantly MSM in the first phase after coming to the general public's attention. They are sometimes seen as gay diseases by people outside the MSM community, as they are closely related to having (gay) sex. In the community there was a palpable fear of infection, lack of knowledge, and dearth of professional help (medical or psychological). People felt left alone, having to cope with the prospect or reality of the disease: in the 80s as well as the present. While MPX has caught us all on the back foot at least there are LGBTQ+ health organisations now, which wasn't the case in the early stages of the AIDS crisis. Both diseases leave their mark on the body: KS-lesions for AIDS and pock lesions in the case of MPX. This is not just a stigma in the general public but also in our community which is oftentimes focused on good looks. There is certainly only a very small group of people who find lesions or pockmarks desirable. So this will diminish the self worth of people affected and their prospects of getting partners. And finally both diseases leave the developing world behind. Jynneos/Imvanex is as scarce as hen's teeth in the developed world. It is however next to inaccessible to developing countries, in some of which MPX is endemic. AIDS ran rampant in Africa during the past decades and ART was slow to take up there due to cost. I fear we will see a similar pattern emerge in the case of MPX. Keeping affected persons from seeking treatment not just because of lack of funds but also out of shame/fear as we find some of the most homophobic places on earth there.

What is allowed on these "Radical Rub Down Tuesdays"? It sounds as if one gets vigorously towelled dry and afterwards slathered in Ben Gay or Vick's Vapor Rub.

If it were 'bottom-cannibalism', wouldn't dildos plugs or even fists have come into play? This 'power cuddling' might be a result of the growing trend of 'sides', i.e. men who do not identify as top, bottom or versatile, and do not seek penetrative sex. [think before following links] https://melmagazine.com/en-us/story/meet-the-sides-gay-men-who-dont-like-anal-sex

So to sum it up, if I poured alcohol over my toy, flambéed it, doused the flames in boiling soapy water and put it afterwards in the freezer, I'd be on the safe side? 😇😉

It might help with Santorum, in all other cases: no, just no.

@greecenipples Thanks for the update on the situation in Australia. The Guardian had some information on Monkeypox in Oz several days ago, when news broke that the Commonwealth Government had bought 450,000 doses of the third-generation Jynneos/Imvanex/whatever-name-they-gave-it-down-under vaccine. [think before following links] [think before following links] https://www.theguardian.com/australia-news/2022/aug/03/monkeypox-vaccine-australia-can-you-get-it-and-who-should-eligibility-side-effects-what-available The article mentioned some Atagi (Australian Technical Advisory Group on Immunisation) advice on who should be prioritised for the vaccine which didn’t sound as strict as what you found on your clinic’s website. But it is interesting to note that it mentioned as a group healthcare workers who will be administering the older vaccine ACAM2000. Jynneos is the preferred vaccine for these groups, but “For healthy non-pregnant adults, where Jynneos is not suitable or not available, ACAM2000 has an established profile and may be considered”. I took that to mean that others not getting Jynneos would be offered vaccination with ACAM2000. You may have a look at what the Australian Government’s Department of Health has to say about MPX and the vaccines. It is however the states and territories which determine who gets the vaccine. Please check what you local administration has to say about that topic. [think before following links] [think before following links] https://www.health.gov.au/health-alerts/monkeypox-mpx/monkeypox-mpx-vaccines

At ninety she might have a tremor in her hands, which may aid her in following the correct scarification procedure.🤪

Thank you for posting this. The source for these numbers is from the product information for Jynneos (or Imvanex in the EU). You may find the complete document on the European Medical Agency at [think before following links] [think before following links] https://www.ema.europa.eu/documents/product-information/imvanex-epar-product-information_en.pdf The FDA has information on its page for Jynneos [think before following links] [think before following links] https://www.fda.gov/vaccines-blood-biologics/jynneos You may find the rates Doctor Carlton quoted on page 8 of the Imvanex product information. They are Seroconversion rates by ELISA in Vaccinia-naïve healthy and special populations in the trial POX-MVA011. It appears that HIV+ individuals have a lower and slower response to the vaccine. If you look a bit further down you'll see the Seroconversion rates by ELISA in Vaccinia-experienced healthy and special populations. They appear even more startling. At the milestones - as mentioned in your post - for HIV+ individuals rates of 57.3, 76.6 and 92.7, while healthy individuals have rates of 62.5, 100, 100. These rates stem from the Phase 2 trial POX-MVA011, which tried to evaluate the safety and immunogenicity of MVA-BN smallpox vaccine in vaccinia-naïve as well as vaccina-experienced HIV infected subjects. The study enrolled 581 subjects: 88 vaccinia naïve and 9 vaccinia-experienced healthy subjects, 352 vaccinia-naïve and 132 vaccinia-experienced HIV infected subjects. You may take note that it's a relatively low number of healthy individuals participating. I'm no statistician and it's quite late here locally so I'll leave it at that.

An interesting if lengthy feature in The Guardian by Steven W Thrasher, professor at Northwestern University.

Unfortunately it's not quite as simple. Leaving aside the issue of side effects (which are major not just minor), there are at least three important reasons not to use ACAM2000 to combat Monkeypox. First of all it's quite difficult to vaccinate with ACAM2000. Jynneos (called Imvanex in the EU/Imvamune in Canada) is given by subcutaneous injection. Every medical practitioner worth their salt should be able to do it. ACAM2000 (and all older vaccines) is administered by scratching a bifurcated needle several times on the skin of the patient. It takes training, skill, and more time to administer than an injection. As a consequence only a small percentage of medical personnel will be qualified to do it. Let's have a look at a description of the procedure: A second major concern is fewer people can be vaccinated due to contraindications. ACAM2000 can't be used in immunocompromised patients (HIV/AIDS or Chemotherapy) or patients with a history of eczema. That excludes some of the people most vulnerable to Monkeypox. Unfortunately it's not just healthy persons who need to be protected. Jynneos is safer to use in patients with the preconditions mentioned above. Thus allowing to protect more people. The third drawback of ACAM2000 is the danger of transmission to others by way of the vaccination lesion. Older vaccines such as ACAM2000 use a live Vaccinia virus which is able to replicate. After vaccination one has a localized infection, with a red itchy sore. You may spread it inadvertently to others (by touch, shared objects and so on) if not enough care preventing contact with the lesion is taken. It's advisable to cover the lesion until the vaccination "takes" (i.e. essentially the Vaccinia infection has run its course). As it's in the hands of the patient to keep it covered it's certainly a procedure more prone to mistakes. One can understand that those responsible are a bit uneasy of that. The Modified Virus Ankara (MVA) used in Jynneos can't replicate. Furthermore the mode of delivery doesn't create a lesion. The slow response and the laggard pace of vaccination efforts makes me angry. Using older stockpiled smallpox vaccines doesn't appear to be the solution to me, however.

Just to add to @rawTOPs list: Pup Davey tried a more humourous way to deal with his monkeypox infection.

The Guardian reports that NHS England is about to start a new screening programme for Hepatitis C. It is part of the WHO global goal to eradicate the disease by 2030. The scheme uses AI (Artificial Intelligence) to screen health records for a number of key risk factors, hoping to identify people living unaware of them being infected. [think before following links] https://www.theguardian.com/society/2022/jul/31/exclusive-nhs-to-use-ai-to-identify-people-at-higher-risk-of-hepatitis-c Hepatitis C is a viral liver infection that has little to no noticeable symptoms until severe liver damage has occurred. Caught early enough the disease can be cured by modern treatments.

The Guardian takes a look at the laggard response to MPX by the US health agencies. [think before following links] https://www.theguardian.com/world/2022/aug/01/monkeypox-us-virus-vaccine-health-response

SilverSteele on Twitter is an example for OF/JFF models dealing openly with their MPX infection.

Thank you for your estimation. You may be able to find more data on MPX ("Affenpocken" in German) on [think before following links] https://survstat.rki.de/Content/Query/Main.aspx There you can customise your query down to state (e.g. Berlin) or even county level (e.g. City of Berlin Friedrichshain-Kreuzberg), by week of notification and so on. It's a bit fiddly to use but a valuable source of information.

The Guardian's 'First Edition' Newsletter has some pieces of information on Monkeypox and the situation in the UK. Sexual health activist and researcher Dr Will Nutland (PrEPster & The LoveTank) and gay Guardian columnist Owen Jones deal with public health messaging not geared towards gay & bisexual men, abstinence-based messaging, the vaccine situation in the UK, and the need to overhaul Britain's sexual health system. [think before following links] https://www.theguardian.com/world/2022/jul/25/monday-briefing-monkeypox-gay-bisexual-men-public-health-who Scroll down to: In depth: ‘Who actually gets the right information is random’

Have had similar experiences that most will let you cum in them. Although I can't be bothered trying to convince someone to take my load, if he asks me to pull out. When I'm close to cumming, there are other things more important to me than changing someone's mind. Most of the time I ask if they want my load as it's always extra hot to hear them beg for it.

Interesting feature in yesterday's The Guardian, one of Britain's mainstream newspapers, about a New Yorker's experience with monkeypox. He describes the progression of the illness, the reaction of the NY healthcare providers and mentions being given TPOXX (Tecovirimat) - the only antiviral medication against MPX. [think before following links] https://www.theguardian.com/world/2022/jul/23/i-literally-screamed-out-loud-in-pain-my-two-weeks-of-monkeypox-hell

True, there's treatment for Hep C. But as spankie correctly started there is no vaccination available that would prevent infection.

FWIW the WHO has just declared Monkeypox a global health emergency. Let's hope international cooperation and coordination works better in this case than at the last declared global health emergency: COVID-19.